| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 1025687-58-4 | R788(FOSTAMATINIB DISODIUM) | R788(Fostamatinib disodium); R788(Fostamatinib disodium); R788, Fostamatinib; R935788 (FostaMatinib disodiuM) | 無 | 詳情 | 供應商 | |
| 957054-30-7 | 2-(1H-吲唑-4-基)-6-[[4-(甲基磺�；�)-1-哌嗪基]甲基]-4-(4-嗎啉基)噻吩并[3,2-D]嘧啶; 2-(1H-吲唑-4-基)-6- | Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morph; Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-; GDC-0941; GDC-0941 free base; 2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine; GDC-0941 bismesylate; 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine; 4-(2-(1H-Indazol-4-yl)-6-((4-(Methylsulfonyl)piperazin-1-yl)Methyl)thieno[3,2-d] |  | C23H27N7O3S2 | 詳情 | 供應商 |
| 850173-95-4 | N,N-二乙基-4-(5-羥基螺[2H-1-苯并吡喃-2,4'-哌啶]-4-基)苯甲酰胺鹽酸鹽; N,N-二乙基-4-(5-羥基螺[2H-1-苯并 | ADL-5859; ADL-5859; N,N-Diethyl-4-(5-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-4-yl)benzamide hydrochloride | 無 | C24H29ClN2O3 | 詳情 | 供應商 |
| 801312-28-7 | 無 | 詳情 | 供應商 | |||
| 938440-64-3 | 5-[2-[(2R,6S)-2,6-二甲基-4-嗎啉基]-4-(4-嗎啉基)吡啶并[2,3-D]嘧啶-7-基]-2-甲氧基苯甲醇; 5-[2-[(2R,6S)- | BENZENEMETHANOL, 5-[2-[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]-4-(4-MORPHOLINYL)PYRIDO[2,3-D]PYRIMIDIN-7; BENZENEMETHANOL, 5-[2-[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]-4-(4-MORPHOLINYL)PYRIDO[2,3-D]PYRIMIDIN-7-YL]-2-METHOXY-, REL-; KU0063794; 5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol; (5-(2-((2R,6S)-2,6-Dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol; rel-5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol; KU0063794(KU63794); KU-0063794(KU 0063794) |  | C25H31N5O4 | 詳情 | 供應商 |
| 1089283-49-7 | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶 | GSK1904529A; GSK1904529A; GSK1904529A : IGF-IR, IGF-IIR inhibitor; N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide; GSK 4529 | 無 | C44H47F2N9O5S | 詳情 | 供應商 |
| 841290-81-1 | R406 | 無 | 詳情 | 供應商 | ||
| 875337-44-3 | N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-B]吡啶-7-氧基)苯基氨基硫代甲�；�)-2-苯乙酰胺; N-(3-氟-4- | N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phen; N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide; MGCD-265 (Synonyms MGCD265); MGCD-265 |  | C26H20FN5O2S2 | 詳情 | 供應商 |
| 908115-27-5 | SNX-5422 | PF-04929113; PF-04929113; SNX-5422; PF-04929113(SNX5422) | 無 | 詳情 | 供應商 | |
| 870281-82-6 | 無 | 詳情 | 供應商 | |||
| 781661-94-7 | 4,9-二氫-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物; 4,9-二氫-1-(2-甲 | YM155; YM155; 4,9-Dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(2-pyrazinylmethyl)-1H-naphth[2,3-d]imidazolium bromide; SepantroniuM broMide | 無 | C20H19BrN4O3 | 詳情 | 供應商 |
| 956958-53-5 | XL147; N-[3-(2,1,3-苯并噻二唑-5-氨基)-2-喹喔啉基]-4-甲基苯磺酰胺; XL147; XL-147; SAR245408; N-[3-(苯并[C] | N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide,; N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide,; XL147; SAR245408; N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylaMino)quinoxalin-2-yl]-4-MethylbenzenesulfonaMide |  | C21H16N6O2S2 | 詳情 | 供應商 |
| 937174-76-0 | 4-[2-(4-氨基-1,2,5-惡二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-? | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4; 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol; GSK 690693; (R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMI |  | C21H27N7O3 | 詳情 | 供應商 |
| 1094614-84-2 | 3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亞甲基]-2,3-二氫-2-氧代-1H-吲哚-6-甲酰胺; 3-[[[3-[(二甲基氨基) | BIX 02188; 3-[[[3-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indole-6-carboxamide; BIX 02188; BIX 02188(BIX-02188 | 無 | C25H24N4O2 | 詳情 | 供應商 |
| 722544-51-6 | 5-[[7-[3-[乙基(2-羥基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺; 5-[[7-[3-[乙基(2 | 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fl; 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-; 2-[5-(7-{3-[ETHYL-(2-HYDROXY-ETHYL)-AMINO]-PROPOXY}-QUINAZOLIN-4-YLAMINO)-2H-PYRAZOL-3-YL]-N-(3-FLUORO-PHENYL)-ACETAMIDE; INH 34; AZD-1152HQPA; AZD1152-HQPA; 2-(3-(7-(3-(Ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-ylamino)-1H-pyrazol-5-yl)-N-(3-fluorophenyl)acetamide; 5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide; AZD1152-HQPA(Barasertib) |  | C26H30FN7O3 | 詳情 | 供應商 |
| 943540-75-8 | 6-[二氟[6-(1-甲基-1H-吡唑-4-基)-1,2,4-噻唑并[4,3-B]吡嗪-3-基]甲基]-喹啉; 6-[二氟[6-(1-甲基-1H-吡唑-4- | J&J Ex-61; J&J Ex-61; Quinoline, 6-[difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-; 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline; JNJ-38877605 |  | C19H13F2N7 | 詳情 | 供應商 |
| 72093-11-9 | 2-氯-3,4-二甲基吡啶; 2-氯-3,4-二甲基吡啶 | NA | 無 | 詳情 | 供應商 | |
| 208260-29-1 | ZM 336372 | ZM 336372; N-[5-(3-DIMETHYLAMINOBENZAMIDO)-2-METHYLPHENYL]-4-HYDROXYBENZAMIDE; ZM 336372; 3-(DIMETHYLAMINO)-N-[3-[(4-HYDROXYBENZOYL)-AMINO]-4-METHYLPHENYL]BENZAMIDE; Zinc00581684 |  | C23H23N3O3 | 詳情 | 供應商 |
| 1197160-78-3 | N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-嗎啉基)-1,3,5-三嗪-2-基]苯基]脲; N-[4-[[4-( | PF-05212384; PF-05212384; PKI587; N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea | 無 | C32H41N9O4 | 詳情 | 供應商 |
| 950769-58-1 | N-(5-叔丁基異惡唑-3-基)-N'-{4-[7-[2-(嗎啉-4-基)乙氧基]咪唑并[2,1-B][1,3]苯并噻唑-2-基]苯基}脲; N-(5-? | N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]; N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea; Quizartinib; Quizartinib AC-220 |  | C29H32N6O4S | 詳情 | 供應商 |